GPT and chronic hepatitis B virus infection: In conclusion, our study provided clinical evidence that combination therapy with LdT+ADV or LAM+ADV leads to significant decreases in serum HBV DNA and ALT levels, without specific damage to renal function in chronic hepatitis B patients.